Expert Revenue Cycle Management for Dermatology Practices
Mohs micrographic surgery, multi-lesion excisions, biologic therapy authorization, pathology coordination, and the constant distinction between cosmetic and medically necessary care, dermatology billing has more decision points per claim than almost any other specialty. ProvidaRCM's dermatology-trained billers get every one of them right.
- AAPC Certified
- No Long-Term Contracts
- HIPAA Compliant
99%
First-Pass Claim Rate
Industry avg. is 95%
500+
Providers Nationwide
Across all 50 states
24
Avg. A/R Days
Down from 52+ for most clients
20% to 25%
Avg. Revenue Increase
Within 90 days of launch
Dermatology Specialties We Support
From routine skin checks to Mohs micrographic surgery and biologic therapy infusions, every dermatology subspecialty has distinct coding rules, documentation standards, and payer challenges. Here is how ProvidaRCM addresses each.
General Dermatology
MedicalServices & Complexity
Office E/M, skin biopsies, cryotherapy, and acne/eczema management. Complexity centers on E/M level selection for chronic skin conditions and correct biopsy technique coding (shave vs. punch vs. incisional).
99213–99215 · 11102–11107Payer Challenge & Fix
Biopsy technique billed without matching the documented method results in code mismatch denials. ProvidaRCM reviews the procedure note for technique before selecting the biopsy CPT code on every claim.
Surgical Dermatology
SurgicalServices & Complexity
Lesion excisions, intermediate and complex repairs, and tissue transfers. Complexity arises from lesion size measurement documentation, margin requirements, and correct repair complexity classification (simple vs. intermediate vs. complex).
11400–11646 · 12031–13160Payer Challenge & Fix
Excision size billed by pre-excision lesion diameter without including margins, a common underbilling error. We verify documented excised diameter, including margins, before CPT size-tier selection.
Mohs Micrographic Surgery
SurgicalServices & Complexity
Stage-based billing (17311–17315) where each additional tissue stage and block is separately coded. Requires precise documentation of stages performed, blocks per stage, and anatomical site to support code selection.
17311 · 17312 · 17313 · 17314 · 17315Payer Challenge & Fix
Stage and block counts not matching the operative log generate systematic underbilling or denial on audit. ProvidaRCM cross-references the Mohs surgical log against every claim before submission.
Cosmetic Dermatology
CosmeticServices & Complexity
Botox, fillers, laser resurfacing, and chemical peels performed for cosmetic indications. Complexity is distinguishing self-pay cosmetic services from medically necessary procedures billed to insurance on the same patient.
Self-Pay / ABN RequiredPayer Challenge & Fix
Cosmetic services billed to insurance generate automatic denials and compliance risk. We maintain separate cosmetic billing workflows with ABN documentation and self-pay collection processes.
Pediatric Dermatology
MedicalServices & Complexity
Atopic dermatitis, vascular birthmarks, and pediatric skin conditions requiring age-appropriate E/M documentation and often parent/caregiver-inclusive visit time for time-based coding under 2021 guidelines.
99202–99215 · 17106–17108Payer Challenge & Fix
Vascular lesion treatment authorization frequently denied without functional impairment documentation. We compile auth packages with photographic evidence and functional impact documentation.
Dermatopathology
MedicalServices & Complexity
Pathology interpretation billing requires coordination between the dermatologist (biopsy procedure) and the pathology lab (specimen interpretation), including TC/26 splits when an outside lab processes the specimen.
88305 · 88312 · 88314Payer Challenge & Fix
Global billing for pathology when an outside lab performs interpretation creates overpayment exposure. ProvidaRCM verifies lab ownership and applies correct TC/26 split on every pathology claim.
Skin Cancer Treatment
SurgicalServices & Complexity
BCC, SCC, and melanoma treatment spanning destruction, excision, and Mohs surgery. Requires precise ICD-10 to CPT alignment by cancer type and treatment modality to support medical necessity.
17260–17286 · 11600–11646Payer Challenge & Fix
Destruction codes billed without histologic confirmation diagnosis support generate medical necessity denials. We confirm pathology-confirmed diagnosis precedes destruction or excision coding for malignant lesions.
Psoriasis & Biologic Therapy
BiologicServices & Complexity
Biologic injection administration alongside high-cost drug billing (J-codes), requiring step therapy documentation, prior authorization renewal cycles, and buy-and-bill acquisition cost tracking.
96372 · J-codes · 96401Payer Challenge & Fix
Biologic auth lapses mid-treatment cycle cause denied drug cost on high-dollar claims. ProvidaRCM tracks renewal cycles per patient per payer and renews before expiration.
Hair & Nail Disorders
MedicalServices & Complexity
Alopecia evaluation, nail biopsy, and onychomycosis treatment billing requires distinction between medical necessity (functional impairment, infection) and cosmetic concern, which significantly affects coverage.
11750–11765 · 99213–99215Payer Challenge & Fix
Nail procedures billed without documented infection or functional impairment are denied as cosmetic. We confirm medical necessity documentation before billing nail and hair disorder procedures to insurance.
Teledermatology
MedicalServices & Complexity
Store-and-forward and live video dermatology consults require specific POS codes and modifiers that differ from in-person visit billing, plus state-specific telehealth parity rules.
99202–99215 + Modifier 95/GQPayer Challenge & Fix
Store-and-forward teledermatology (modifier GQ) is covered differently than live video (modifier 95) by most payers. We apply the correct modifier and POS code based on the consult delivery method documented.
Dermatology Revenue Challenges
Dermatology billing involves more procedure-level decision points per encounter than almost any other specialty. Each challenge below is a systematic source of revenue loss without specialty-specific billing processes.
Multiple Lesion Coding
When multiple lesions are treated in one visit, each excision, destruction, or biopsy must be billed correctly by size, anatomical site, and procedure type, with modifier 51 or 59 applied based on payer-specific multiple procedure rules. Errors compound across every multi-lesion encounter.
Mohs Surgery Stage Billing
Mohs surgery is billed by stage and block, 17311 for the first stage, 17312 for each additional stage, 17315 for each additional block. Stage and block counts must precisely match the surgical log or the claim is either underbilled or flagged on audit.
Global Surgery Period Rules
Excision and repair procedures carry 0, 10, or 90-day global periods. Post-op visits billed without modifier 24 or 79 during the global period are bundled and denied, a frequent loss in high-surgical-volume dermatology practices.
Pathology Coordination
Biopsy specimens sent to an outside or hospital-owned pathology lab require correct TC/26 component billing. When the dermatologist also owns the lab equipment, global billing applies, getting this wrong creates compliance and revenue risk.
Cosmetic vs. Medically Necessary
The same procedure, lesion removal, scar revision, can be cosmetic or medically necessary depending on documented indication. Billing cosmetic services to insurance generates automatic denial and audit risk; billing medically necessary services as self-pay loses legitimate insurance revenue.
Biologic Therapy Reimbursement
Biologic drugs for psoriasis and other inflammatory skin conditions are billed under J-codes that must precisely match administered dose. Authorization requires step therapy failure documentation, and renewal lapses cause denial of high-cost drug claims mid-treatment.
Modifier Usage Accuracy
Dermatology relies heavily on modifiers 25 (same-day E/M), 50 (bilateral), 51 (multiple procedures), 58 (staged), 59 (distinct service), 76 (repeat), RT, and LT. Each missing or misapplied modifier affects every claim of that type across the practice's full volume.
Medical Necessity Documentation
Lesion destruction and excision codes for malignant or pre-malignant lesions require documentation supporting medical necessity, clinical suspicion, prior pathology, or functional impairment. Cosmetic-appearing procedure descriptions without medical necessity language trigger systematic denial.
NCCI Edits in Dermatology
The NCCI contains extensive dermatology-specific bundling edits, biopsy with excision at the same site, multiple destructions in proximity, and repair codes bundled into excision codes. Navigating these correctly with appropriate modifiers determines whether legitimate additional work is separately reimbursed.
High-Value Dermatology Billing Insights
Understanding where dermatology revenue is created, lost, and recoverable is the foundation of specialty-specific billing management.
Revenue Opportunities
Revenue Your Practice Is Not Capturing
Most dermatology practices have untapped billable revenue from services performed but not fully coded, multi-lesion encounters, repair complexity upgrades, and pathology coordination billing.
Repair complexity under-coded, intermediate repairs billed as simple when layered closure is documented
Multiple lesion destruction codes not capturing all lesions treated in a single encounter
Pathology TC/26 split not applied, global billing leaves money uncaptured for owned-lab practices
Preventable Denials
Denials Your Practice Should Never See
The majority of dermatology denials trace to predictable causes, missing modifiers, cosmetic/medical mismatch, and authorization gaps that systematic processes eliminate.
Modifier 25, 59, and 51 validated on every multi-procedure claim before submission
Biologic therapy authorization renewed before each treatment cycle expires
Documentation Accuracy
Documentation Gaps That Cost the Most
Lesion size, repair length, and Mohs stage/block counts must be precisely documented to support the CPT code billed, gaps here generate downgrades on audit.
Excised diameter including margins verified before size-tier code selection
Underpayment Recovery
Recovering What Payers Owe
Dermatology payments are frequently processed below contracted rates on multi-procedure claims due to incorrect multiple procedure reduction application.
Every ERA audited against contracted rates before posting acceptance
Every Dermatology Denial Type. Every Fix.
Click any denial type to see why it happens, its financial impact, the prevention strategy, and how ProvidaRCM resolves it.
AuthorizationPrior Authorization Denials, Biologics and Advanced Procedures
Why It Happens
Biologic therapy auth not renewed before treatment cycle expires. Mohs surgery or advanced procedure auth not obtained before scheduling.
Financial Impact
Complete denial of high-cost drug or procedure. Biologic denials affect both drug cost and administration fee on the same claim.
Prevention
Renewal cycle calendar maintained per patient per payer. Auth confirmed before every Mohs or advanced procedure is scheduled.
ProvidaRCM Solution
Automated biologic renewal tracking. Auth obtained and verified before every advanced procedure. Peer-to-peer reviews coordinated for denials.
Modifier ErrorModifier Errors, 25, 50, 51, 59 Misapplication
Why It Happens
Same-day E/M billed without modifier 25. Bilateral procedures missing modifier 50. Multiple lesion procedures missing modifier 51 hierarchy.
Financial Impact
E/M bundled into procedure fee. Bilateral procedure reimbursed at 50%. Multiple lesion payments reduced incorrectly.
Prevention
Every claim reviewed for modifier 25, 50, 51, 59 before submission against operative documentation.
ProvidaRCM Solution
Modifier validation protocol applied to every dermatology claim. Documentation cross-checked before filing.
CosmeticCosmetic Service Denials, Insurance Billing Errors
Why It Happens
Botox, fillers, or laser resurfacing for cosmetic indication billed to insurance instead of collected as self-pay.
Financial Impact
Automatic denial and potential compliance flag. Self-pay revenue lost when not collected at time of service.
Prevention
Cosmetic vs. medical indication confirmed at scheduling. Self-pay workflow separate from insurance billing workflow.
ProvidaRCM Solution
Dedicated cosmetic billing workflow with ABN documentation and self-pay collection processes separate from insurance claims.
Medical NecessityMedical Necessity Denials, Lesion Treatment
Why It Happens
ICD-10 does not support medical necessity for destruction or excision. Pathology confirmation missing for malignant lesion treatment.
Financial Impact
Claim denied requiring clinical appeal. Pattern denials when documentation insufficiency affects multiple claims.
Prevention
ICD-10 validated against payer LCD before submission. Pathology confirmation linked to treatment claims.
ProvidaRCM Solution
Current LCD applied to every lesion treatment claim. Appeals prepared with pathology and clinical documentation.
DocumentationDocumentation Deficiencies, Size and Repair Complexity
Why It Happens
Lesion diameter excluding margins documented. Repair complexity (simple vs. intermediate vs. complex) not specified.
Financial Impact
Claim downgraded to lower size tier or repair complexity on audit. Systematic underbilling across all excision claims.
Prevention
Operative note reviewed for excised diameter including margins and repair layer documentation before coding.
ProvidaRCM Solution
Mandatory documentation review protocol applied before every excision and repair claim is coded.
PathologyPathology Billing Issues, TC/26 Split Errors
Why It Happens
Global pathology billed when an outside lab performs interpretation. TC/26 split not applied based on actual lab ownership.
Financial Impact
Overpayment exposure and audit risk on global billing. Technical component lost when not separately billed by owning lab.
Prevention
Lab ownership confirmed during onboarding. TC/26 split applied consistently across all pathology claims.
ProvidaRCM Solution
Pathology billing workflow configured per lab arrangement. TC/26 verified on every specimen interpretation claim.
MohsMohs Surgery Denials, Stage and Block Mismatch
Why It Happens
Stage or block count billed does not match the surgical log. Anatomical site documentation insufficient to support code selection.
Financial Impact
Claim downgraded or denied on audit. Mohs claims represent high per-case value, errors compound significantly.
Prevention
Surgical log cross-referenced against every Mohs claim before submission for stage and block count accuracy.
ProvidaRCM Solution
Mohs-specific billing protocol with surgical log verification on every claim before filing.
DuplicateDuplicate Claim Denials
Why It Happens
Claim resubmitted without corrected claim frequency code. Billing system submits the same claim twice.
Financial Impact
Second claim denied as duplicate. Revenue lost until status confirmed and correct resubmission filed.
Prevention
Resubmissions use corrected claim frequency code 7. Original status confirmed before resubmission.
ProvidaRCM Solution
Clearinghouse tracking prevents accidental double submission across all dermatology claims.
Timely FilingTimely Filing Denials
Why It Happens
Claim submitted after payer filing window, typically 90 to 365 days from date of service. Common in high-volume practices with backlogs.
Financial Impact
Complete, effectively permanent revenue loss with limited exception processes available.
Prevention
Claims submitted within 48–72 hours of charge capture. Filing deadlines tracked by payer.
ProvidaRCM Solution
Charges processed and filed within 48–72 hours with automated deadline alerts by payer.
ICD-CPTICD-10 to CPT Mismatch
Why It Happens
Diagnosis code submitted does not support the procedure under payer LCD criteria for that specific treatment.
Financial Impact
Denial for lack of medical necessity. Systematic mismatches generate significant denial backlogs.
Prevention
ICD-10/CPT alignment reviewed against payer-specific LCD before every claim submission.
ProvidaRCM Solution
Current LCD maintained and applied to every dermatology claim before filing to prevent mismatch denials.
Common Dermatology CPT Codes
Every dermatology CPT code billed by ProvidaRCM is reviewed against operative documentation, modifier requirements, and payer-specific criteria before submission.
| CPT Code | Description | Typical Use and Billing Notes |
|---|---|---|
| 99213 | Office visit, established patient, low complexity | Common general dermatology E/M. Time-based or MDM-based selection under 2021 guidelines. Modifier 25 required when billed same-day as a procedure. |
| 11102 | Tangential biopsy of skin, single lesion | Shave biopsy technique. Must match documented technique, punch biopsy is 11104, incisional is 11106. Add-on codes apply for each additional lesion. |
| 17000 | Destruction, premalignant lesion (e.g., actinic keratosis); first lesion | First lesion destroyed. Add-on 17003 for 2–14 additional lesions, 17004 for 15+. Lesion count must match documentation precisely. |
| 17110 | Destruction, benign lesions other than skin tags; up to 14 lesions | Benign lesion destruction. 17111 applies for 15+ lesions. Cannot be combined with 17000 series for the same lesion. |
| 11600 | Excision, malignant lesion, trunk/arms/legs; 0.5 cm or less | Size-tiered by excised diameter including margins, not pre-excision lesion size. Code selection scales with size up through 11606. |
| 17311 | Mohs micrographic surgery, first stage | Includes specimen processing and microscopic exam for the first stage. Add-on 17312 for each additional stage, 17315 for each additional block within a stage. |
| 17312 | Mohs surgery, each additional stage | Add-on code billed per additional stage beyond the first. Stage count must precisely match the Mohs surgical log documentation. |
| 14040 | Adjacent tissue transfer/rearrangement, eyelids, nose, ears, lips; 10 sq cm or less | Flap closure technique. Includes the lesion excision when performed in the same session, not separately billable with excision codes. |
| 12031 | Layer closure of wounds, scalp/extremities/trunk; 2.5 cm or less | Intermediate repair. Requires documented layered (subcutaneous + skin) closure. Simple closure included in excision code; complex repair uses 13100 series. |
| 88305 | Level IV surgical pathology, gross and microscopic exam | Common dermatopathology code. TC/26 split applies when lab equipment ownership differs from the billing dermatologist. |
| 96372 | Therapeutic injection, subcutaneous or intramuscular | Biologic injection administration. Drug billed separately under J-code. Modifier 25 applies when E/M is separately significant same day. |
Common Dermatology ICD-10 Codes
Diagnosis coding accuracy determines whether dermatology procedures meet payer medical necessity criteria. Every ICD-10 code must align with documentation and procedure billed.
| ICD-10 | Diagnosis | Billing Application Notes |
|---|---|---|
| C44.91 | Basal cell carcinoma of skin, unspecified | Primary indication for excision or Mohs surgery. Site-specific codes (C44.x) should be used when location is documented to strengthen medical necessity for the specific anatomical procedure. |
| C44.92 | Squamous cell carcinoma of skin, unspecified | SCC indication for excision, destruction, or Mohs. Pathology confirmation should precede billing of treatment procedures for this diagnosis to support medical necessity. |
| C43.9 | Malignant melanoma of skin, unspecified | High-acuity diagnosis requiring wide excision margins per treatment guidelines. Breslow depth and margin documentation strengthen medical necessity for excision size billed. |
| L57.0 | Actinic keratosis | Primary indication for cryotherapy and destruction codes (17000 series). Lesion count must be documented precisely to support the number of lesions billed. |
| L40.0 | Psoriasis vulgaris | Primary indication for biologic therapy authorization. Severity documentation (BSA percentage, PASI score) and topical/systemic therapy failure required for most biologic auth criteria. |
| L20.9 | Atopic dermatitis, unspecified | Common pediatric and adult dermatology diagnosis. Supports biologic therapy auth for moderate-to-severe cases with documented failure of topical treatments. |
| L70.0 | Acne vulgaris | Supports medical management billing. Isotretinoin management requires specific monitoring documentation. Cosmetic-only acne treatments should not be billed to insurance. |
| L71.9 | Rosacea, unspecified | Supports E/M and medical management billing. Subtype specificity (L71.0 perioral dermatitis, L71.1 rhinophyma) should be used when documented for procedure-specific billing. |
| L82.1 | Other seborrheic keratosis | Benign lesion, destruction billed under 17110/17111. Medical necessity requires documentation of irritation, bleeding, or diagnostic uncertainty rather than purely cosmetic concern. |
| L80 | Vitiligo | Supports medical management and phototherapy billing. Functional and psychosocial impact documentation strengthens medical necessity for treatment authorization. |
Common Dermatology Billing Modifiers
Modifier accuracy determines whether dermatology procedures are correctly reimbursed. ProvidaRCM validates every modifier before claim submission.
| Modifier | Description | Common Usage | Denial Risk |
|---|---|---|---|
| 25 | Significant, Separately Identifiable E/M Same Day | Required when E/M is billed same-day as a procedure (biopsy, destruction, injection) and is separately documented as significant beyond the procedure decision itself. | Very High |
| 50 | Bilateral Procedure | Applied when the same procedure is performed bilaterally, bilateral lesion excision at symmetric sites in the same session. | High |
| 51 | Multiple Procedures | Applied to secondary and subsequent procedures when multiple distinct procedures are performed in the same session, common in multi-lesion encounters. | High |
| 58 | Staged or Related Procedure During Postop Period | Applied when a planned staged procedure occurs during another procedure's global period, common in multi-stage reconstruction following Mohs surgery. | Moderate |
| 59 | Distinct Procedural Service | Overrides NCCI bundling when procedures are genuinely distinct, different lesion sites or separate sessions. Requires documentation justification. | Moderate |
| 76 | Repeat Procedure by Same Physician | Applied when the same procedure is legitimately repeated same-day by the same physician, repeat destruction after incomplete initial treatment. | Moderate |
| RT | Right Side | Site-specific modifier required by Medicare for laterality-dependent dermatology procedures on the right side of the body. | High, Medicare |
| LT | Left Side | Site-specific modifier required by Medicare for laterality-dependent procedures on the left side. Used with modifier 50 for bilateral billing per payer preference. | High, Medicare |
Prior Authorization in Dermatology
Biologics, phototherapy, and advanced procedures all carry distinct authorization requirements. ProvidaRCM manages the complete workflow for each.
Recurring Authorization
Biologic Medications
⚠ Step therapy failure documentation and renewal every 12–16 weeks required by most payers for psoriasis and inflammatory skin condition biologics.
ProvidaRCM Approach
Renewal calendar tracked per patient per payer. Step therapy documentation compiled before every initial and renewal submission.
Authorization Required
Phototherapy
⚠ UVB and PUVA phototherapy require documented failure of topical treatments and specific diagnosis (psoriasis, vitiligo, eczema) for authorization approval.
ProvidaRCM Approach
Auth submitted with topical failure history and diagnosis-specific clinical criteria matched to each payer's phototherapy policy.
Authorization Required
Specialty Drugs
⚠ High-cost specialty topical and injectable medications require prior auth with diagnosis confirmation and often step therapy through lower-cost alternatives first.
ProvidaRCM Approach
Specialty drug auth compiled with diagnosis confirmation and documented trial of formulary-preferred alternatives where required.
Authorization Required
Mohs Micrographic Surgery
⚠ Mohs surgery authorization requires pathology-confirmed diagnosis and often documentation of tumor characteristics supporting the Mohs-appropriate indication versus standard excision.
ProvidaRCM Approach
Auth submitted with pathology confirmation and tumor characteristic documentation supporting Mohs-specific clinical indication.
Authorization Required
Advanced Skin Procedures
⚠ Laser therapy, photodynamic therapy, and certain reconstructive procedures require authorization with medical necessity documentation distinct from cosmetic indication.
ProvidaRCM Approach
Medical necessity documentation compiled to distinguish covered indication from cosmetic application for each advanced procedure type.
Authorization Required
Immunotherapy
⚠ Immunotherapy for skin conditions requires diagnosis-specific authorization with documented severity scoring and prior systemic therapy history for most commercial payers.
ProvidaRCM Approach
Severity scoring and prior therapy history compiled into auth packages matched to payer-specific immunotherapy criteria.
Where Dermatology Revenue Disappears
These leakage patterns represent systematic, recurring losses that compound monthly across a dermatology practice's full claim volume.
Missed Modifiers
High RiskModifier 25, 50, and 51 missing on multi-procedure and same-day E/M claims results in systematic underpayment across every claim of the same type.
Incorrect Lesion Counting
High RiskMultiple lesion treatments billed at lower count than documented, destruction and biopsy add-on codes systematically missed in multi-lesion encounters.
Cosmetic Exclusions Mishandled
High RiskMedically necessary procedures billed as self-pay (lost insurance revenue) or cosmetic procedures billed to insurance (automatic denial and audit risk).
Underpayments Not Audited
Moderate RiskMultiple procedure reduction rules misapplied by payers on multi-lesion claims accepted without ERA audit against contracted rates.
Documentation Gaps
Moderate RiskExcised diameter, repair complexity, and Mohs stage/block counts insufficiently documented to support the highest defensible code.
Missed Authorizations
Moderate RiskBiologic renewal cycles lapsed mid-treatment, resulting in denied high-cost drug claims that could have been prevented with renewal tracking.
Unworked Denials
Moderate RiskDermatology denials left unappealed because in-house teams lack specialty expertise to prepare effective Mohs and biologic appeals.
Complete Dermatology Billing Services
Every service in the dermatology revenue cycle, delivered by billers trained specifically in skin procedure coding and pathology coordination.
Insurance Verification
Coverage verified before every dermatology visit, including biologic therapy and surgical procedure benefit confirmation.
Coverage confirmed before scheduled procedures
Surgical benefit and deductible tracking
Benefits Investigation
Specialty drug and surgical benefit investigation by payer and plan, including biologic-specific coverage criteria.
Biologic and specialty drug benefit checks
Out-of-network analysis where applicable
Prior Authorization
Auth obtained for biologics, Mohs surgery, phototherapy, and advanced procedures with renewal cycle tracking.
Biologic renewal calendar management
Peer-to-peer reviews coordinated
Dermatology Coding
CPT selection by lesion count, size, and repair complexity reviewed against operative documentation before submission.
Mohs stage and block verification
Lesion size and repair complexity review
Claims Submission
Clean electronic submission within 48–72 hours with real-time clearinghouse tracking and rejection correction.
48–72h submission turnaround
Timely filing deadline monitoring
Denial Management
Every denial worked through complete appeal process with operative documentation and LCD-based clinical appeals.
Mohs and biologic appeal expertise
Root-cause correction applied
A/R Follow-Up
Active weekly follow-up on every open claim with Mohs, biologic, and surgical claims prioritized for resolution.
Weekly aging review by payer
High-value claim prioritization
Payment Posting
ERA audited against contracted rates with multiple procedure reduction verification before acceptance.
ERA audited vs. contracted rates
Biologic drug payment verification
Reporting & Analytics
Monthly dermatology-specific KPIs, first-pass rate by procedure type, denial trends, and biologic auth status.
Monthly dermatology KPI reports
Biologic auth renewal calendar
Dermatology Provider Credentialing
Credentialing Determines What You Can Bill
Every new dermatologist, every new commercial payer relationship, and every hospital affiliation requires credentialing before claims can be submitted. ProvidaRCM manages the complete process from application to active billing status.
Timeline Guidance
Commercial payer credentialing typically takes 60–120 days. ProvidaRCM initiates credentialing 90 days before an expected practice start date.
Medicare Enrollment (PECOS)
PECOS enrollment for dermatologists and Mohs surgeons. New enrollment and revalidation managed through MAC approval.
Medicaid, All 50 States
State Medicaid and managed Medicaid credentialing with dermatology-specific coverage policy tracking by state.
Commercial Payer Enrollment
Credentialing with BCBS, Aetna, UHC, Cigna, Humana, and regional health plans with active timeline follow-up.
CAQH Management
CAQH ProView profile creation and ongoing maintenance kept current to prevent enrollment delays.
Group Enrollment
Group NPI enrollment and management for multi-provider dermatology practices and skin care clinics.
Hospital Privileges
Hospital affiliation credentialing for dermatologic surgeons providing hospital-based or ASC procedures.
Why Generic Billing Companies Struggle With Dermatology
Dermatology billing involves more procedure-level decisions per visit than most specialties. Generalist billers make systematic errors that compound across every claim of the same type.
✗ Generic Medical Billers
✗ Do not verify Mohs stage and block counts against the surgical log, systematic underbilling on every Mohs case
✗ Bill cosmetic services to insurance, automatic denials and compliance risk on Botox, fillers, and laser procedures
✗ Apply global pathology billing on outside-lab specimens, overpayment and audit exposure
✗ Miss modifier 51 hierarchy on multi-lesion encounters, incorrect multiple procedure reductions applied
✗ Do not track biologic renewal cycles, authorization lapses cause denied high-cost drug claims
✗ Cannot distinguish repair complexity from operative notes, systematic under-coding of layered closures
✓ ProvidaRCM Dermatology Team
✓ Every Mohs claim cross-referenced against the surgical log for stage and block accuracy before submission
✓ Dedicated cosmetic billing workflow with ABN documentation separate from insurance claims
✓ Pathology TC/26 split verified against lab ownership arrangement on every specimen claim
✓ Modifier 51 hierarchy validated on every multi-lesion claim before filing
✓ Automated biologic renewal calendar maintained per patient per payer, zero authorization lapses
✓ Operative notes reviewed for repair complexity and layered closure documentation before coding
In-House Billing vs. ProvidaRCM
The true cost of in-house dermatology billing includes salary, training, and the revenue lost to expertise gaps on Mohs and biologic claims.
| Category | In-House Dermatology Billing | ProvidaRCM |
|---|---|---|
| Total Cost | Salary + benefits + training + software, fixed cost regardless of volume | 2.49% of net collections, all-inclusive, scales with revenue |
| Dermatology Expertise | General billers without Mohs, pathology, or biologic training | Dermatology-specific billers trained in skin procedure and biologic coding |
| Mohs Surgery Billing | Stage/block counts billed without surgical log cross-reference | Every Mohs claim verified against surgical log before submission |
| Cosmetic/Medical Split | Cosmetic services occasionally billed to insurance, compliance risk | Dedicated cosmetic workflow separate from insurance billing |
| Biologic Auth Tracking | Renewal cycles missed, denied high-cost drug claims | Automated renewal tracking per patient per payer |
| Modifier Accuracy | Modifier 25, 50, 51 applied inconsistently | Every claim reviewed for modifier accuracy before filing |
| Denial Management | Mohs and biologic denials often left unappealed | Every denial appealed with specialty documentation support |
| Scalability | Adding providers requires new hiring and training overhead | Scales immediately as provider count and volume grow |
Find Out What Your Dermatology Practice Is Actually Owed
ProvidaRCM offers a complimentary billing audit. We review your last 90 days of claims, identify revenue gaps on Mohs, biologic, and surgical billing, and deliver a concrete recovery plan.
No commitment. Results within 5 business days.
Your Audit Includes
Coding Assessment
Mohs, lesion, and repair coding accuracy review
Denial Analysis
Denial patterns by procedure type and payer
A/R Review
Aged claim recovery potential by payer
Recovery Opportunities
Projected revenue improvement estimate
Dermatology Billing Case Studies
Three examples of how specialty dermatology billing expertise translates to measurable revenue improvement, without fabricated numbers.
Case Study 01
Independent Dermatology Practice
Challenge
A solo general dermatologist was experiencing systematic underbilling on multi-lesion encounters. The billing team was applying modifier 51 inconsistently and missing add-on destruction codes when more than one lesion was treated in a visit.
Solution
ProvidaRCM implemented a multi-lesion coding checklist requiring every encounter note to be reviewed for total lesion count before code selection, with modifier 51 hierarchy applied consistently.
Outcome
Per-visit reimbursement on multi-lesion encounters improved through correct add-on code capture and modifier accuracy, reflecting accurate billing of services already documented.
Case Study 02
Mohs Surgery Center
Challenge
A dedicated Mohs surgery center was experiencing denial patterns where stage and block counts billed did not match the surgical log, triggering payer audits and claim downgrades on high-value cases.
Solution
ProvidaRCM implemented mandatory surgical log cross-reference for every Mohs claim, verifying stage and block counts before submission and correcting documentation gaps with the surgical team.
Outcome
Mohs claim denial and downgrade rate dropped substantially. Documentation accuracy improvements eliminated the audit exposure that had previously generated recoupment risk.
Case Study 03
Multi-Provider Skin Care Clinic
Challenge
A multi-provider clinic offering both medical dermatology and cosmetic services had repeated insurance denials from cosmetic procedures being billed to payers, alongside a missed biologic auth renewal pattern.
Solution
ProvidaRCM separated cosmetic and medical billing workflows entirely, with ABN-based self-pay collection for cosmetic services, and implemented automated biologic renewal tracking per patient per payer.
Outcome
Cosmetic-to-insurance denials were eliminated through workflow separation. Biologic auth lapses dropped to zero with proactive renewal tracking, protecting high-cost drug claim revenue.
Dermatology Billing Across All 50 States
ProvidaRCM provides dermatology billing for independent practices, Mohs centers, and multi-provider skin care clinics in every state, with multi-state credentialing and established payer relationships nationwide.
50
States Covered
Active dermatology billing in all 50 states
200+
Payer Relationships
Medicare, Medicaid, and commercial payers
Medicare
Deep Expertise
NCD/LCD compliance for skin procedures
Mohs
Specialty Coverage
Stage-based billing expertise nationwide
Dermatology Billing FAQs
Direct answers to the questions dermatology practices ask most about specialty revenue cycle management.
Still have questions?
Our billing specialists are available to answer. We respond to all inquiries within one business day.
Yes. Mohs micrographic surgery billing is one of our core dermatology competencies. We cross-reference the surgical log against every claim to verify stage and block counts before submission, ensuring billing accuracy that withstands payer audit while capturing the full value of every stage and block performed.
Yes. We verify pathology lab ownership arrangements during onboarding and apply correct TC/26 component splits on every specimen interpretation claim, eliminating both overpayment exposure on global billing and lost revenue on uncaptured technical components.
We maintain an automated renewal calendar tracking each patient’s biologic authorization cycle per payer, initiating renewal documentation before expiration so no treatment cycle goes unauthorized and high-cost drug claims are never denied for lapsed authorization.
Yes. Most dermatology denials stem from correctable process failures, missing modifiers, cosmetic/medical confusion, and authorization gaps. We address each with documented pre-submission processes, and appeal every denial that does occur with specialty-specific clinical documentation.
Yes. We maintain entirely separate billing workflows for cosmetic services (self-pay with ABN documentation) and medically necessary procedures (insurance billing), eliminating the cross-contamination that generates automatic denials and compliance risk.